Gefitinib

✅ Treats Lung Cancer
✅ Inhibits Cancer Cell Growth
✅ Oral Administration
✅ Effective Targeted Therapy
✅ Minimal Side Effects

This product is currently out of stock and unavailable.

Gefticip Tablet is prescribed for treating non-small cell lung cancer, specifically in patients where the cancer has metastasized (spread to other body parts), who possess abnormal epidermal growth factor receptor (EGFR) genes, and haven’t undergone prior cancer treatment.

This medication can be taken with or without meals, though maintaining a consistent daily schedule enhances effectiveness. Continue treatment as directed by your physician. Treatment duration depends on individual response and medical requirements. Strict adherence to your doctor’s instructions is crucial, as improper use or overdosing may lead to severe adverse effects. While benefits may take weeks or months to manifest, continue treatment unless advised otherwise by your doctor.

Common side effects include nausea, skin rashes, vomiting, and weight reduction. Severe diarrhea may occur – maintain hydration or consult your doctor if persistent. This medication increases sun sensitivity; wear protective clothing and sunscreen outdoors. Immediately inform your doctor if you experience mouth ulcers, vision changes, or breathing difficulties. Regular liver function tests may be required during treatment.

Inform your healthcare provider about all medications you’re taking, as Gefticip may interact with other drugs. This medication is contraindicated during pregnancy and breastfeeding. Both male and female patients must use effective contraception during treatment. When taking antacids or other medications, maintain at least a 2-hour interval after Gefticip dosage.

THERAPEUTIC APPLICATIONS OF GEFTICIP TABLET

  • Management of non-small cell lung carcinoma

THERAPEUTIC ADVANTAGES OF GEFTICIP TABLET

In Non-small cell lung carcinoma

As a predominant form of lung cancer affecting both smokers and non-smokers, non-small cell lung cancer responds to Gefticip Tablet treatment, which may be administered as monotherapy or combined with other agents. This potent cytotoxic medication requires thorough risk-benefit evaluation with your oncologist. Patients should maintain adequate hydration and abstain from alcohol consumption during therapy.

ADVERSE EFFECTS OF GEFTICIP TABLET

Most adverse reactions are transient and resolve as your system adapts to the medication. Consult your physician if symptoms persist or cause concern.

Frequently observed reactions to Gefticip

  • Gastrointestinal disturbances (diarrhea)
  • Dermatological effects (dry skin, rashes)
  • Decreased appetite
  • Nausea and vomiting
  • Oral inflammation (stomatitis)
  • Generalized fatigue
  • Body weight reduction

ADMINISTRATION GUIDELINES

Ingest this medication whole as prescribed, without chewing, crushing, or breaking the tablet. While Gefticip Tablet can be taken irrespective of meals, maintaining a regular dosing schedule optimizes therapeutic outcomes.

MECHANISM OF ACTION

Gefticip Tablet functions as an antineoplastic agent by inhibiting the activity of aberrant proteins that stimulate cancerous cell proliferation, thereby impeding or decelerating cancer progression.

Important Notice:

Our objective is exclusively to provide medically validated, precise, and reliable information to consumers. However, this content should NOT serve as an alternative to professional medical advice. The presented information is strictly educational and may not encompass all potential side effects, drug interactions, warnings, or precautions. Always consult your healthcare provider regarding any medical condition or treatment. This information aims to complement, not replace, professional medical guidance.

Strength

250 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Cipla Inc

Treatment

Non-small cell lung cancer

Generic Brand

Geftinib

Reviews

There are no reviews yet

Add a review
Gefitinib Gefitinib
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot